<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02041663</url>
  </required_header>
  <id_info>
    <org_study_id>AOR 10106</org_study_id>
    <nct_id>NCT02041663</nct_id>
  </id_info>
  <brief_title>Septic cArdiac Deficiency and MenIngococcal seveRe Sepsis</brief_title>
  <acronym>SAMIRA</acronym>
  <official_title>Septic cArdiac Deficiency and MenIngococcal seveRe Sepsis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Use of brain natriuretic peptide to evaluate the cardiac function in the course of
      meningococcal septic shock or severe sepsis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVES: determining sensibility and specificity of BNP blood level to detect myocardial
      dysfunction in septic shock or severe sepsis due to Neisseria meningitidis in children.

      METHODS: Prospective multicentric clinical trial including 7 French pediatric intensive care
      units. Serial cardiac ultra sounds and blood sampling will be done for patients hospitalized
      for purpura fulminans beginning at the time of admission in pediatric intensive care. Any
      child from 6 months to 18 years without preexisting cardiac disease and presenting with
      purpura fulminans will be enrolled after obtaining consent of both parents. From adult's
      studies on septic shock and BNP, a total number of 30 patients was calculated to be necessary
      to prove the interest of BNP in this indication.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2012</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">November 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Repeated brain natriuretic peptide (BNP) blood level</measure>
    <time_frame>Up to day 5</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Repeated cardiac echography</measure>
    <time_frame>Up to day 5</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PRISM II gravity score</measure>
    <time_frame>Up to day 5</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Organ failure PELOD score</measure>
    <time_frame>Up to day 5</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Troponin rate</measure>
    <time_frame>Up to day 5</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mortality and morbidity (aftereffects)</measure>
    <time_frame>Day 28 and hospital discharge</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">35</enrollment>
  <condition>Meningococcal Infections</condition>
  <condition>Septic Shock</condition>
  <condition>Severe Sepsis</condition>
  <arm_group>
    <arm_group_label>Population</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Repeated brain natriuretic peptide dosages and cardiac echographies up to day 5</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>BNP</intervention_name>
    <description>Repeated brain natriuretic peptide dosages and cardiac echographies up to day 5</description>
    <arm_group_label>Population</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children

          -  6 months to 18 years aged

          -  without previous cardiac pathology

          -  hospitalized in the participating pediatric intensive care units for serious sepsis
             with extensive purpura

        Exclusion Criteria:

          -  Heart malformative disorder with right-left shunt

          -  Pre-existent known cardiac insufficiency whatever is the origin

          -  Concomitant participation in another trial

          -  Patient in period of exclusion from another trial

          -  Not membership in a national insurance scheme
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean Bergougnoux, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jean Bergounioux, MD</last_name>
    <phone>+33 (0)1 44 49 42 18</phone>
    <email>jean.bergounioux@nck.aphp.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>AP-HP, Necker hospital</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean Bergougnoux, MD</last_name>
    </contact>
    <investigator>
      <last_name>Jean Bergougnoux, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 20, 2014</study_first_submitted>
  <study_first_submitted_qc>January 20, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 22, 2014</study_first_posted>
  <last_update_submitted>September 29, 2017</last_update_submitted>
  <last_update_submitted_qc>September 29, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 2, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>brain natriuretic peptide</keyword>
  <keyword>cardiac function</keyword>
  <keyword>meningococcal infections</keyword>
  <keyword>septic shock</keyword>
  <keyword>severe sepsis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Toxemia</mesh_term>
    <mesh_term>Shock, Septic</mesh_term>
    <mesh_term>Meningococcal Infections</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Natriuretic Peptide, Brain</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

